[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Dermatologicals in Estonia

September 2023 | 22 pages | ID: D7AE48D5F39EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Sales of dermatologicals have benefited from the return to normal activities following the lifting of pandemic-related restrictions. Consumers are out in public again and socialising and are consequently looking to treat any conditions to ensure thy look their best. This has supported volume growth of medicated shampoos, antiparasitics/lice (head and body) treatments and cold sore treatments in 2023, whilst hair loss treatments have remained stable following a strong 2022.

Euromonitor International's Dermatologicals in Estonia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Dermatologicals market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
DERMATOLOGICALS IN ESTONIA
KEY DATA FINDINGS
2023 DEVELOPMENTS
Return to normal life benefits dermatologicals in 2023
E-commerce continues to grow, helping consumers overcome stigmas related to dermatological conditions
GSK Consumer Healthcare leads with its well-known and widely available brands
PROSPECTS AND OPPORTUNITIES
Overall stagnation with pockets of growth
Rising health awareness hampers growth
Hair loss treatment has a strong potential for growth
CATEGORY DATA
Table 1 Sales of Dermatologicals by Category: Value 2018-2023
Table 2 Sales of Dermatologicals by Category: % Value Growth 2018-2023
Table 3 NBO Company Shares of Dermatologicals: % Value 2019-2023
Table 4 LBN Brand Shares of Dermatologicals: % Value 2020-2023
Table 5 Forecast Sales of Dermatologicals by Category: Value 2023-2028
Table 6 Forecast Sales of Dermatologicals by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN ESTONIA
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture
2023 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 8 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2018-2023
Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 13 Penetration of Private Label by Category: % Value 2018-2023
Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2022-2023
DISCLAIMER
DEFINITIONS
SOURCES
Summary 2 Research Sources


More Publications